Latest News and Press Releases

Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical data confirms the...

COPENHAGEN, Denmark, December 2, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present...

New pre-clinical data demonstrates that the novel EVX-B2 mRNA vaccine candidate triggers a targeted immune response The specific immune response leads to the elimination of the gonorrhea bacteriaThe...

Siyata Mobile (NASDAQ:SYTA) will host an exhibitor's booth at the International Wireless Communications Expo ("IWCE") 2024 in partnership with Verizon

VANCOUVER, British Columbia, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) (“Siyata” or the “Company”), a global developer and vendor of Push-to-Talk over Cellular (PoC)...

VANCOUVER, British Columbia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular (PoC) devices and...

Siyata Mobile Inc. (Nasdaq: SYTA) received a $900,000 order for existing international Defense and EMS customers for the Company’s UV350 and PTT devices

New York, United States, Oct. 31, 2023 (GLOBE NEWSWIRE) -- In-vitro diagnostics, or IVD, are medical devices and reagents used to examine body fluids and tissues to diagnose diseases, conditions,...

Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates in disease diagnosis, monitoring,...

New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Albumin & Creatinine Tests market size is slated to expand at ~19% CAGR between 2023 and 2035. The market is poised to garner a revenue of...